As we get older, we definitely seem to get more reflective, and I certainly have been doing quite a bit of this of late!
(Feb 4, 2009)We have previously suggested on this site a growing need for pharma to connect to the world-wide health technology assessment (HTA) agenda (State of Fear, April 2008 [1]). [1] http://social.eyeforpharma.com/content/pharma-strategy/state-fear
(Mar 10, 2009)Times continue to be tough for the industry and this author has been doing some more reflection that has manifested in three linked articles.
(Apr 30, 2009)Kevin Appareti, global director for Medical Science Liaison at Philips Healthcare, explains how to motivate KOLs and how to measure their value
The Mobile Health Competition is now closed, but the journey is just beginning for the winning idea.
Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs